Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive13

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive12

Views

Views
November 20230
December 20230
January 20246
February 20241
March 20241
April 20240
May 20244
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
France1
 

Top cities views

Views
Boardman6
Chicago1